44 results
SC 14F1
YBGJ
Yubo International Biotech Ltd
29 Sep 20
Statement regarding change in majority of directors
9:15am
of the Company’s shareholders during the two fiscal years ended February 29, 2020.
Code of Ethics
The Company has adopted a Code of Ethics
SC 14F1
YBGJ
Yubo International Biotech Ltd
6 Jul 20
Statement regarding change in majority of directors
11:39am
as defined in Item 401 of Regulation S-B.
Code of Ethics
The Company has adopted a Code of Ethics applicable to its employees and consultants
8-K
EX-10.7
YBGJ
Yubo International Biotech Ltd
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
during the performance of this Agreement are in compliance with laws, regulations, rules, industry norms and ethics.
Party B shall conscientiously
S-1
EX-10.7
YBGJ
Yubo International Biotech Ltd
6 May 21
IPO registration
6:03am
actions taken during the performance of this Agreement are in compliance with laws, regulations, rules, industry norms and ethics.
Party B shall
S-1
EX-10.1
YBGJ
Yubo International Biotech Ltd
6 May 21
IPO registration
6:03am
property, observe professional ethics, actively participate in the trainings organized by Party A to improve his/her ideological consciousness
8-K
EX-10.2
08g bv1rz
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
8-K
EX-10.1
qsut82d
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
S-1
EX-10.3
locqhv9og
6 May 21
IPO registration
6:03am
8-K
EX-10.3
w1e7vl9sre8sc9hlddcy
14 Jan 21
Entry into a Material Definitive Agreement
2:54pm
S-1
EX-10.2
nj9o0rjbexgv875
6 May 21
IPO registration
6:03am